| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jun―25 |
Immunization of Mice with the pVAXrbd DNA Vaccine by Jet Injection Induces a Stronger Immune Response and Protection against SARS-CoV-2 Compared to Intramuscular Injection by Syringe |
D. N. Kisakov, M. B. Borgoyakova, L. A. Kisakova, E. V. Starostina, O. V. Pyankov, A. V. Zaykovskaya, et al. (+10) O. S. Taranov, E. K. Ivleva, N. B. Rudometova, V. A. Yakovlev, E. V. Tigeeva, M. Sh. Azaev, I. M. Belyakov, A. P. Rudometov, A. A. Ilyichev, L. I. Karpenko |
| 2 |
[GO] |
2024―Aug―07 |
Molecular Ion Channel Blockers of Influenza A and SARS-CoV-2 Viruses |
Yu. N. Vorobjev |
| 3 |
[GO] |
2024―Apr―09 |
A Bioinformatics Method for Identification of Human Proteases Active against Viral Envelope Glycoproteins: A Case Study on the SARS-CoV-2 Spike Protein |
E. V. Matveev, G. V. Ponomarev, M. D. Kazanov |
| 4 |
[GO] |
2023―Jun―18 |
Development of a Series of Neutralizing Nanobodies against SARS-CoV-2 Spike Protein |
V. A. Zhuchkov, S. V. Ivanov, J. E. Kravchenko, S. P. Chumakov |
| 5 |
[GO] |
2023―Apr―26 |
Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2 |
L. A. Oleinik, P. G. Madonov, M. B. Pykhtina |
| 6 |
[GO] |
2022―Dec―09 |
High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera |
E. A. Astakhova, M. G. Byazrova, G. M. Yusubalieva, V. F. Larichev, V. P. Baklaushev, A. V. Filatov |
| 7 |
[GO] |
2022―Oct―05 |
Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2 |
D. V. Glazkova, E. V. Bogoslovskaya, F. A. Urusov, N. P. Kartashova, E. A. Glubokova, A. V. Gracheva, et al. (+7) E. B. Faizuloev, G. V. Trunova, V. A. Khokhlova, O. A. Bezborodova, A. A. Pankratov, I. A. Leneva, G. A. Shipulin |
| 8 |
[GO] |
2022―Jun―03 |
Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines |
A. A. Dolskiy, I. V. Grishchenko, S. A. Bodnev, A. A. Nazarenko, A. M. Smirnova, A. K. Matveeva, et al. (+9) L. E. Bulychev, A. S. Ovchinnikova, T. V. Tregubchak, A. V. Zaykovskaya, I. R. Imatdinov, O. V. Pyankov, E. V. Gavrilova, R. A. Maksyutov, D. V. Yudkin |
| 9 |
[GO] |
2022―Jun―03 |
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2 |
A. A. Maslova, E. C. Matyugina, E. Yu. Shustova, V. P. Volok, L. I. Kozlovskaya, S. N. Kochetkov, A. L. Khandazhinskaya |
| 10 |
[GO] |
2022―Feb―12 |
MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features |
A. N. Kucher, Iu. A. Koroleva, A. A. Zarubin, M. S. Nazarenko |
| 11 |
[GO] |
2021―Dec―17 |
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein |
M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, D. V. Shanshin, A. A. Isaeva, V. S. Nesmeyanova, et al. (+11) N. V. Volkova, S. V. Belenkaya, D. E. Murashkin, D. N. Shcherbakov, E. A. Volosnikova, E. V. Starostina, L. A. Orlova, N. V. Danilchenko, A. V. Zaikovskaya, O. V. Pyankov, A. A. Ilyichev |
|
